Synopsys
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Synopsys in real time with a live news feed covering Synopsys stock news, official press releases, company announcements, and an archive of historical Synopsys news. ...more
Loading news...
Loading more...
5:09 PM | Friday | May 22, 2026
Sign in to download news snippet
On May 22, 2026, Synopsys Inc (SNPS) shares rose 4.1% to a current price of $524.74. This price is situated between a 52-week high of $651.73 and a low of $376.
No data available for this time period.
Change the time range to see results.
On May 22, 2026, Synopsys Inc (SNPS) shares rose 4.1% to a current price of $524.74. This price is situated between a 52-week high of $651.73 and a low of $376.
SNPS heads into Q2 earnings results with AI-driven chip demand and Synopsys.ai adoption expected to support revenue growth.
Read full article
SNPS heads into Q2 earnings results with AI-driven chip demand and Synopsys.ai adoption expected to support revenue growth.
Read full article
Evaluate the expected performance of Synopsys (SNPS) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read full article
Synopsys is a critical AI value chain bottleneck, yet its stock has underperformed despite robust fundamentals and market position. I rate SNPS a 'strong buy' due to its essential EDA tools, virtual duopoly status, and undervaluation versus peers on both P/E and EV/Revenue bases. My DCF and comps analysis yield a fair value of $586.83, implying 17.7% upside, supported by 15% annualized revenue growth and 42% operating margins.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read full article
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read full article
Investors looking for stocks in the Computer - Software sector might want to consider either Progress Software (PRGS) or Synopsys (SNPS). But which of these two stocks offers value investors a better bang for their buck right now?
Read full article
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) below $500 looks priced for an AI story the business does not fully support.
Read full article
Artificial intelligence is no longer just about who builds the fastest chips.
Read full article
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) has staged one of the more dramatic comebacks in semiconductor software, climbing 21.78% in the past month after a brutal stretch through late 2025.
Read full article
Synopsys (SNPS) has positioned itself as a dominant EDA software provider, further strengthened by the Ansys acquisition and structural AI tailwinds. The Ansys deal expands SNPS's TAM by 63% to $31B, enabling integrated chip-to-system simulation and reinforcing its competitive moat. Despite a forward P/E of ~35.8, SNPS's compounding EPS growth, high margins, and visible catalysts justify a long-term Quality Growth thesis.
Read full article
No data available for this time period.
Change the time range to see results.